This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adams, M. M.
Right arrow Articles by Moyer, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adams, M. M.
Right arrow Articles by Moyer, R. W.

 Previous Article  |  Next Article 

Journal of Virology, October 2007, p. 11084-11095, Vol. 81, No. 20
0022-538X/07/$08.00+0     doi:10.1128/JVI.00423-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Rabbitpox Virus and Vaccinia Virus Infection of Rabbits as a Model for Human Smallpox{triangledown}

Mathew M. Adams, Amanda D. Rice, and R. W. Moyer*

Department of Molecular Genetics and Microbiology, Box 100266, 1600 SW Archer Road, ARB R2-231, University of Florida College of Medicine, Gainesville, Florida 32610-0266

Received 27 February 2007/ Accepted 26 July 2007

The threat of smallpox release and use as a bioweapon has encouraged the search for new vaccines and antiviral drugs, as well as development of new small-animal models in which their efficacy can be determined. Here, we reinvestigate a rabbit model in which the intradermal infection of rabbits with very low doses of either rabbitpox virus (RPV) or vaccinia virus Western Reserve (VV-WR) recapitulates many of the clinical features of human smallpox. Following intradermal inoculation with RPV, rabbits develop systemic disease characterized by extensive viremia, numerous secondary lesions on the skin and mucocutaneous tissues, severe respiratory disease, death by 9 days postinfection, and, importantly, natural aerosol transmission between animals. Contrary to previous reports, intradermal infection with VV-WR also resulted in a very similar lethal systemic disease in rabbits, again with natural aerosol transmission between animals. When sentinel and index animals were cohoused, transmission rates approached 100% with either virus, with sentinel animals exhibiting a similar, severe disease. Lower rates of transmission were observed when index and sentinel animals were housed in separate cages. Sentinel animals infected with RPV with one exception succumbed to the disease. However, the majority of VV-WR-infected sentinel animals, while becoming seriously ill, survived. Finally, we tested the efficacy of the drug 1-O-hexadecyloxypropyl-cidofovir in the RPV/rabbit model and found that an oral dose of 5 mg/kg twice a day for 5 days beginning 1 day before infection was able to completely protect rabbits from lethal disease.


* Corresponding author. Mailing address: Department of Molecular Genetics and Microbiology, Box 100266, 1600 SW Archer Road, ARB R2-231, University of Florida College of Medicine, Gainesville, FL 32610-0266. Phone: (352) 273-5230. Fax: (352) 273-5232. E-mail: rmoyer{at}ufl.edu

{triangledown} Published ahead of print on 8 August 2007.


Journal of Virology, October 2007, p. 11084-11095, Vol. 81, No. 20
0022-538X/07/$08.00+0     doi:10.1128/JVI.00423-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Liu, J., Wennier, S., Reinhard, M., Roy, E., MacNeill, A., McFadden, G. (2009). Myxoma Virus Expressing Interleukin-15 Fails To Cause Lethal Myxomatosis in European Rabbits. J. Virol. 83: 5933-5938 [Abstract] [Full Text]  
  • Tang, Z., Parekh, P., Turner, P., Moyer, R. W., Tan, W. (2009). Generating Aptamers for Recognition of Virus-Infected Cells. Clin. Chem. 55: 813-822 [Abstract] [Full Text]